Lakefront Biotherapeutics | GLPG - الدائنين التجاريين





الدائنين التجاريين تغيير تاريخ
argenx SE USD 719M 164.73M 2026-06
AstraZeneca USD 22.89B 388M 2026-06
Biogen USD 403.9M 45.4M 2026-06
Genmab DKK 116M 110M 2026-06
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 7M 2026-06
GRIFOLS EUR 1B 160M 2026-06
Hikma Pharmaceutical USD 715M 104M 2025-12
Incyte USD 1.39B 1.16B 2026-06
Merck EUR 2.07B 61M 2026-06
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Novartis USD 4.26B 64M 2026-06
Roche Holding CHF 5.54B 237M 2026-06
Sanofi EUR 23.6B 888M 2026-06
UCB EUR 4.04B 755M 2025-12
Vertex Pharmaceuticals USD 3.61B 135M 2026-06